Fanny Pélerin

Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans

Marie Lefèvre, Silvia Racedo, Muriel Denayrolles et al. · Regulatory Toxicology and Pharmacology · 2016 · 145 citations · Full text

Life Sciences, Food Science, Microbiology +17

A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome

Guillaume Pineton de Chambrun, Christel Neut, Amélie Chau et al. · Digestive and Liver Disease · 2014 · 115 citations

Medicine, Nutritional Sciences, Pharmacology +12

Therapeutic activity of a<i>Saccharomyces cerevisiae</i>-based probiotic and inactivated whole yeast on vaginal candidiasis

Eva Pericolini, Elena Gabrielli, Nathalie Ballet et al. · Virulence · 2016 · 86 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Randomized double blind placebo-controlled trial of<i>Saccharomyces cerevisiae</i>CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation

Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet et al. · United European Gastroenterology Journal · 2015 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis

Elena Gabrielli, Eva Pericolini, Nathalie Ballet et al. · Beneficial Microbes · 2018 · 38 citations · Full text

Life Sciences, Immunology, Microbiology +17